Paul Peter Tak, Chief Executive Officer at Candel Therapeutics, Inc. (CADL), sold 45,056 shares at $6.47 ($292K) on 2024-07-17, disclosed to the SEC on 2024-07-19.
Open-market sale of $292k CADL by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.47 | 22,528 | $146K | 50.0% |
| 2 | $6.47 | 22,528 | $146K | 50.0% |
| Total | $6.47 avg | 45,056 | $292K | 100% |
| Filing → |
| CADL | SELL | 2025-01-17 | $314K | — | Filing → |
| CADL | SELL | 2025-01-10 | $348K | — | Filing → |
| CADL | SELL | 2024-12-03 | $445K | — | Filing → |